OTC Derivatives Summit Asia 2017: 20% Discount for OTC Space Readers

Since Regulation Asia’s last OTC Derivatives Summit, new uncertainties have emerged. Extant challenges—such as banks’ struggle for profitability amid shrinking balance sheets and increasingly burdensome capital adequacy requirements—appear no closer
February 20, 2017 - Editor

Since Regulation Asia’s last OTC Derivatives Summit, new uncertainties have emerged. Extant challenges—such as banks’ struggle for profitability amid shrinking balance sheets and increasingly burdensome capital adequacy requirements—appear no closer to being resolved. A seeming lack of regulatory coordination, exemplified by Hong Kong, Singapore and Australia not carrying through with the 1 September deadline for initial margin, has only added to the problem. OTC Space registered readers can access a 20% discount on registration.

OTC Derivatives Summit Asia 2017

Thursday 16th March 2017: Singapore

Since Regulation Asia’s last OTC Derivatives Summit, new uncertainties have emerged. Extant challenges—such as banks’ struggle for profitability amid shrinking balance sheets and increasingly burdensome capital adequacy requirements—appear no closer to being resolved. A seeming lack of regulatory coordination, exemplified by Hong Kong, Singapore and Australia not carrying through with the 1 September deadline for initial margin, has only added to the problem. This raft of uncertainties means that one year on, it has become harder, not less difficult, to predict how Asia-Pacific’s OTC derivatives markets will evolve. Yet it also means the imperative to attempt to understand where we stand, and where we're going, has become even stronger.

Speakers will include:

  • ANDREA SCHNOZ: Head of Asia Finance Regulatory Policy, Barclays
  • AVE KING: Executive Director, Regional Compliance for F&O and OTC Clearing, J.P. Morgan
  • BRAD MACLEAN: Managing Director, Regulation Asia
  • BERTRAND D’ANSELME: Head of Derivatives Clearing Services, APAC, BNP Paribas
  • CONOR CUNNINGHAM: Founder & CEO, APAC, BNP Paribas Securities Services, ACUO
  • DR. FREDERICK SHEN: Head of Business Management, Global Treasury, OCBC
  • GREG BALLESTY: Senior Risk Management SME, SmartStream
  • JONATHAN QUIE: Counsel, Simmons & Simmons
  • KARIM CHABANE: Director, Head of APAC Collateral Management, Citi Futures, Clearing and Collateral
  • LUKE BRERETON: Co-Head ECLiPSe, Financial Markets, Wholesale Bank, Standard Chartered
  • NICK WAKEFIELD: Managing Director & Co-Founder, Regulation Asia
  • SAM AHMED: Co-Founder & MD, Deriv Asia
  • SAMUEL RIDING: Editor, Regulation Asia
  • SHAUN MURRAY: Managing Director, Head of Strategic Collateral Management, Standard Chartered Bank
  • SIMON MCKNIGHT: Partner, Simmons & Simmons
  • TIM CLARSEN: Head of Risk Management Business Solutions, Murex
  • VALERIAN CRASTO: Chief Operating Officer, Treasury & Markets, DBS
  • YUTAKA IMANISHI: Chief Executive Officer Asia-Pacific, TriOptima
  • YVES TOMBALLE: Head of Market & Liquidity Risk Ex-Japan, Bank of Tokyo-Mitsubishi UFJ

The Agenda is summarised here:

OTC Derivatives Summit Asia 2017 Agenda

The event is being held at The Westin Singapore, and registration is currently priced at:

$699 – Market Participants ($559.20 with OTC Space discount)

$899 – Service Providers ($719.20 with OTC Space discount)

Registered readers with The OTC Space can receive a 20% discount on the above registration prices, either by clicking here or entering the code 'OTCSPACEOTC20OFF' at checkout.


Popular
Most Viewed

Image